![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
Stroke prevention |
Hepatitis C |
Free Subscription
1 Eur J Gastroenterol Hepatol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Hepatitis C is free of charge.
The nationwide trends in hospital admissions, deaths, and costs related to
hepatitis C stratified by psychiatric disorders and substance use: an analysis of
US hospitals between 2016 and 2019.
Eur J Gastroenterol Hepatol. 2022 Dec 23. doi: 10.1097/MEG.0000000000002498.
PubMed
Abstract available
Letter to the editor: Successful treatment of multidrug-resistant hepatis C after
>12 months of continuous therapy with direct-acting antivirals.
Hepatology. 2023;77:E26-E27.
PubMed
Non-selective Beta Blockers, Hepatic Decompensation and Mortality in Cirrhosis: A
National Cohort Study.
Hepatology. 2022 Aug 19. doi: 10.1002/hep.32737.
PubMed
Abstract available
Short-term hepatocyte function and portal hypertension outcomes of
sofosbuvir/velpatasvir for decompensated hepatitis C-related cirrhosis.
J Gastroenterol. 2023 Feb 2. doi: 10.1007/s00535-023-01963.
PubMed
Abstract available
Sustained virological response in an HCV-infected patient on an enzyme-inducing
anti-epileptic agent despite undetectable trough plasma levels of velpatasvir.
J Hepatol. 2023 Jan 25:S0168-8278(23)00027-2. doi: 10.1016/j.jhep.2023.
PubMed
Second-phase hepatitis C plasma viral kinetics directly reflects reduced
intrahepatic burden of HCV.
J Infect Dis. 2023 Feb 1:jiad025. doi: 10.1093.
PubMed
Abstract available
Usefulness of dried blood spot samples for monitoring hepatitis C treatment
outcome and reinfection among people who inject drugs in a test-and-treat
program.
J Med Virol. 2023 Feb 2. doi: 10.1002/jmv.28544.
PubMed
Abstract available
Safety and effectiveness of 8 weeks of Glecaprevir/Pibrentasvir in challenging
HCV patients: Italian data from the CREST study.
PLoS One. 2023;18:e0280165.
PubMed
Abstract available
Disease burden among migrants in Morocco in 2021: A cross‑sectional study.
PLoS One. 2023;18:e0281129.
PubMed
Abstract available
Impact of HCV Treatment on Recurrence of Hepatocarcinoma After Liver
Transplantation.
Transplant Proc. 2023 Jan 25:S0041-1345(22)00884.
PubMed
Abstract available
Thank you for your interest in scientific medicine.
This policy is made possible thanks to
a media sponsorship by